January 26, 2011

New Staphylococcal vaccine to be developed for ruminants

Centegen Inc, together with Merial, has entered into an exclusive licensing partnership for the expansion and global trade of its proprietary vaccine, CEN-102, designed to lessen staphylococcal infections in ruminants.

Staphylococcal infections are an increasing concern in livestock. The CEN-102 vaccine elicits potent antigen-specific T-cell and B-cell responses not present in unvaccinated animals.

The vaccine aims to protect against spontaneous staphylococcal infections, reduce the need for livestock antibiotic use, and significantly improve milk quality and cattle health. The vaccine incorporates an antigen expressed on the cell surface throughout the entire life-cycle of all tested strains and species of staphylococci.